David Iglesias, MD - Research

Research at a glance

Top areas of exploration

Endometrial Neoplasms , 9 publications
Metformin , 5 publications
Uterine Neoplasms , 4 publications
Carcinoma, Endometrioid , 4 publications

Research activity

24 publications

934 citations

Why is this important?

Active clinical trials

Comparing Two Surgical Procedures in Individuals with Ovarian Cancer+BRCA1 Mutations(SOROCk)

This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the鈥�

Investigator: David Iglesias
Status: Accepting Candidates
Ages: 35 Years - 50 Years
Sexes: Female

My publications

24 publications

2020

Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study.

Clinical cancer research : an official journal of the American Association for Cancer Research

鈥�

2020

Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society.

Gynecologic oncology

鈥�

2020

Venous Thromboembolism Treatment and Prevention in Cancer Patients: Can We Use Pills Yet?

Current treatment options in oncology

鈥�

2019

Rare Case of Mixed Metastatic Placental Site Trophoblastic Tumor and Choriocarcinoma.

Journal of oncology practice

鈥�

2017

Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Gynecologic oncology

鈥�

网红黑料